Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Nike    NKE

NIKE (NKE)
Mes dernières consult.
Most popular
Delayed Quote. Delayed  - 10/20 10:00:32 pm
53.06 USD   +0.70%
10/20 DOW MOVERS : Ge, csco
10/20 NIKE : VaporMax Flyknit SE
10/19 NIKE : Air Force 1 Low SB51 Comeback
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

NIKE, Inc. : Nike To Support Livestrong; 'Saddened' It Was Misled by Armstrong

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/18/2013 | 01:30pm CEST
   By Melodie Warner 
 

Nike Inc. (NKE) said it will continue to support the Livestrong Foundation, although it already terminated its contract with former professional cyclist Lance Armstrong in October.

In an interview with Oprah Winfrey that aired Thursday evening, Mr. Armstrong said he used performance-enhancing drugs to win his seven Tour de France titles. While being treated for testicular cancer, he created the Lance Armstrong Foundation, which is now known as the Livestrong Foundation. In October, Mr. Armstrong stepped down as chairman of the charity amid fallout from doping allegations.

On Friday, Nike said it doesn't condone the use of illegal performance-enhancing drugs in any manner and the company remains "saddened after being misled for more than a decade."

The maker of sports apparel pledged continued support of Livestrong's initiatives to help people affected by cancer.

Write to Melodie Warner at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on NIKE
10/20 DOW MOVERS : Ge, csco
10/20 NIKE : VaporMax Flyknit SE
10/19 NIKE : Air Force 1 Low SB51 Comeback
10/19 NIKE JUST ISN’T DOING IT THIS : Goldman
10/19 Dow closes above 23,000 mark in 54-day run-up
10/18DJNIKE : Jersey Rips on LeBron James in NBA Debut
10/17 NIKE, INC. : to Host Investor Day on October 25, 2017
10/17 FACTBOX - DOW BREACHES 23,000 INTRAD : facts & figures
10/17 NIKE : and Samuel Ross Present the AF1 A-COLD-WALL*
10/16 NIKE : Jason Petrie on the LEBRON 15
More news
News from SeekingAlpha
10/22 QUARTERLY REVIEW OF DIVGRO : Q3-2017
10/21 Stocks to watch next week
10/20 Has Under Armour Bottomed?
10/20 Skechers lights a torch in retail sector
10/20 THROWING THE CHALLENGE FLAG : Tanger Is Not An Insane Discount
Financials ($)
Sales 2018 35 781 M
EBIT 2018 4 649 M
Net income 2018 3 921 M
Finance 2018 2 332 M
Yield 2018 1,46%
P/E ratio 2018 22,56
P/E ratio 2019 19,73
EV / Sales 2018 2,35x
EV / Sales 2019 2,20x
Capitalization 86 568 M
Chart NIKE
Duration : Period :
Nike Technical Analysis Chart | NKE | US6541061031 | 4-Traders
Technical analysis trends NIKE
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 39
Average target price 58,7 $
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Mark G. Parker Chairman, President & Chief Executive Officer
Eric D. Sprunk Chief Operating Officer
Andrew Campion Chief Financial Officer & Executive Vice President
Philip Hampson Knight Chairman-Emeritus
Alan B. Graf Independent Director
Sector and Competitors